ARKK
ThematicARK Innovation ETF
ARK · Tracks (actively managed — no index) · Inception Oct 31, 2014
Composite score
Based on a 0.75% expense ratio.
Based on $6.53B in net assets.
Top-10 holdings represent 49.5% of net assets.
Thematic base · ETF wrapper · 0.00% TTM yield.
The composite is a weighted average of the four core sub-scores above (cost, tax efficiency, liquidity, concentration). Missing sub-scores fall back to the per-category median when the category has at least 50% data coverage, so funds without (e.g.) parsed N-PORT holdings aren't accidentally boosted by renormalization. Tracking quality is shown where computable but isn't currently part of the composite weighting. See methodology for formulas, the tracking-quality partial-coverage rationale, and the dimensions we deliberately don't score (methodology v0.5.1).
Use ARKK in our tools
Tool · Cost
Compare ARKK's fee against another fund
Compounds the 0.75% expense ratio against a peer over decades.
Tool · Overlap
Compare ARKK's holdings with peers
Pairwise holdings heatmap, pre-loaded with similar Thematic funds.
Tool · TLH
Find a tax-loss harvesting partner for ARKK
Ranks every catalog fund by holdings overlap, flags wash-sale risk.
Tool · Placement
Where should this fund live across your accounts?
Asset-location optimizer — places each fund in taxable / tax-deferred / Roth.
Top holdings
| # | Holding | Weight |
|---|---|---|
| 1 | TESLA INC | 9.74% |
| 2 | TEMPUS AI INC | 5.36% |
| 3 | ADVANCED MICRO DEVICES INC | 5.18% |
| 4 | CRISPR THERAPEUTICS AG | 4.98% |
| 5 | SHOPIFY INC | 4.37% |
| 6 | ROKU INC | 4.33% |
| 7 | ROBINHOOD MARKETS INC | 4.30% |
| 8 | COINBASE GLOBAL INC | 4.23% |
| 9 | CIRCLE INTERNET GROUP INC | 3.84% |
| 10 | PALANTIR TECHNOLOGIES INC | 3.13% |
Compare ARKK with another fund
Or skim the closest-overlap funds below.
Similar ETFs by holdings overlap
Open ARKK at a brokerage
Affiliate links — opening an account through these earns PlainIndex a one-time referral. Scoring is computed before any affiliate consideration; see our methodology and funding disclosure.